Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Donald Jones, MD, Vice President, Global Strategy & Market Development, Qualcomm Life, discusses the emergence of wireless technology in healthcare and describes two examples, the AirStrip remote ICU monitoring device…
Seniors eligible for Medicare have choices when it comes to receiving medical services. They can either enroll in a fee for service system or in the Medicare Advantage…
Alan Greene, MD, Founder, DrGreene.com, discusses the optimal time for umbilical cord clamping, and how early clamping may contribute to iron deficiency anemia in the newborn. Filmed at FutureMed,…
Alan Greene, MD, Founder, DrGreene.com, describes the concepts that underpin the Society For Participatory Medicine, which encourages physicians and patients to collaborate in health care. Filmed at FutureMed, in…
Sheri Fink, MD, PhD, Senior Fellow, New America Foundation, reminds us that low-tech solutions, and imaginative innovation are sometimes better than modern, electricity-dependent technologies in times of crisis. Filmed at…
Martin Kohn, MD, MS, Chief Medical Scientist, Care Delivery Systems, IBM Research, talks about Watson, the IBM supercomputer capable of natural language processing, and the role machines like…
Ian H. Robertson, PhD, Chair in Psychology at Trinity College Dublin and author of The Winner Effect, wants to teach you how to be a winner. “The Winner Effect” is a…
Osteoarthritis (OA) is the most common form of arthritis, often involving the knee. OA is also a major reason most patients have a knee replacement. A new study…
Journalist David Ewing Duncan predicts a flood of patient data made available by smart phone apps and other consumer electronic devices. He suggests that this data, ultimately, will…
NEW YORK (Reuters Health) – Men with isolated high-grade prostatic intraepithelial neoplasia (HGPIN) are at relatively high risk for developing prostate cancer, and treatment with toremifene does not…
